- ImpactScore™
- 100
- Very Positive
- EvidenceScore™
- Emerging
- Score 59 · Based on 1 study
- ConsistencyScore™
- unclear
- Not enough independent studies
Educational Visits Improve Metformin Prescribing for Type 2 Diabetes
Última actualización 5 de julio de 2026
Key finding
The use of metformin increased by 5.9% after the individual AD visit.
This study evaluated the impact of academic detailing and group visits on prescribing practices for Type 2 Diabetes, finding significant increases in metformin and insulin prescriptions.
Quick read
Study at a glance
The essential study design details in one scan.
EvidenceScore™
Moderate
Study type
RCTs
Follow-up
Long-Term (1–5 y)
Risk of bias
Some Concerns
Guarda este estudio en tu Evidence Tracker para encontrarlo facilmente cuando lo necesites.
Plain-language summary
What this paper says
A plain-language read of the study's main message and where it applies.
Study focus
This study evaluated the impact of academic detailing and group visits on prescribing practices for Type 2 Diabetes, finding significant increases in metformin and insulin prescriptions.
Clinical relevance
Improving prescribing practices for Type 2 Diabetes is crucial for patient management and outcomes. The significant increases in medication prescriptions following targeted interventions suggest that educational strategies can effectively enhance clinical practice and patient care.
Keep in mind
The study's effectiveness remains unclear due to limited data on long-term outcomes. The sample size and demographic diversity may limit generalizability. The control group did not receive any intervention, which may affect comparative results.
Published in
Referencia de la Revista
Publication details and source links for this paper.
Harald CL, Øyvind S, Roar D, Hege SB, Olav S. Impact of Academic Detailing and Group Visits on Prescribing for Type 2 Diabetes: A Randomized Controlled Trial. Journal of General Internal Medicine. 2024;39(16):3243-3252. doi:10.1007/s11606-024-09014-z
Efectos Principales
Metformin prescribing increased by 5.9% after the individual AD visit (p=0.006).
Insulin prescribing increased by 19.1% after the group meeting (p=0.001).
GLP-1 analogues prescribing increased by 32.2% after the group meeting.
Evidence network
How this study fits
Understand where this research contributes within the broader evidence network.
Evidence Context
This study contributes evidence to Group Meeting, Individual Academic Detailing Visit and GLP-1, Insulin Prescribing, Metformin Prescribing, and 1 more.
This study contributes evidence to
Primary intervention
Group Meeting
Primary outcomes
- GLP-1
- Insulin Prescribing
- Metformin Prescribing
Primary intervention
Primary outcomes
Evidence relationships
Intervention and outcome relationships this study adds to the evidence network.
Editorial context
Why this study matters
See why this paper is useful beyond its individual results.
Evidence network role
This section describes how the study fits into the current evidence network. It does not determine whether an intervention works on its own.
0
Related topics
8
Evidence pairs
0
Related studies
Why it is useful
- Contributes to 8 evidence relationships
- Includes primary outcome data
- Linked to 0 direct semantic evidence topics
Core evidence
Study findings
The primary outcomes reported in this study.
- ImpactScore™
- 100
- Very Positive
- EvidenceScore™
- Emerging
- Score 59 · Based on 1 study
- ConsistencyScore™
- unclear
- Not enough independent studies
- ImpactScore™
- 100
- Very Positive
- EvidenceScore™
- Emerging
- Score 59 · Based on 1 study
- ConsistencyScore™
- unclear
- Not enough independent studies
Total T2D Drugs Prescribing
Group Meeting → Total T2D Drugs Prescribing
Group Meeting → Total T2D Drugs Prescribing
- ImpactScore™
- 100
- Very Positive
- EvidenceScore™
- Emerging
- Score 59 · Based on 1 study
- ConsistencyScore™
- unclear
- Not enough independent studies
- ImpactScore™
- 100
- Very Positive
- EvidenceScore™
- Emerging
- Score 59 · Based on 1 study
- ConsistencyScore™
- unclear
- Not enough independent studies
Insulin Prescribing
Individual Academic Detailing Visit → Insulin Prescribing
Individual Academic Detailing Visit → Insulin Prescribing
- ImpactScore™
- 100
- Very Positive
- EvidenceScore™
- Emerging
- Score 59 · Based on 1 study
- ConsistencyScore™
- unclear
- Not enough independent studies
Metformin Prescribing
Individual Academic Detailing Visit → Metformin Prescribing
Individual Academic Detailing Visit → Metformin Prescribing
- ImpactScore™
- 100
- Very Positive
- EvidenceScore™
- Emerging
- Score 59 · Based on 1 study
- ConsistencyScore™
- unclear
- Not enough independent studies
Total T2D Drugs Prescribing
Individual Academic Detailing Visit → Total T2D Drugs Prescribing
Individual Academic Detailing Visit → Total T2D Drugs Prescribing
- ImpactScore™
- 100
- Very Positive
- EvidenceScore™
- Emerging
- Score 59 · Based on 1 study
- ConsistencyScore™
- unclear
- Not enough independent studies
Build your personal Evidence Workspace
Create a free account to save studies and evidence pages, organize your personal Evidence Tracker, and keep the research you care about in one place.
Today's Activity
Your Evidence Workspace
Saved this study
Your free account becomes your personal diabetes evidence workspace.
Evidence Tracker
12 tracked topics
Saved Studies
48 studies
Research Notes
Coming Soon
Weekly Evidence Digest
Coming Soon
La Evidencia Sugiere
- Metformin prescribing rose by 5.9% after individual visits.
- Insulin prescriptions increased by 19.1% following group meetings.
- GLP-1 analogue prescribing increased by 32.2% after group meetings.
A quién se aplica
- Adults diagnosed with Type 2 Diabetes.
- Healthcare providers involved in diabetes management.
Tener en Cuenta
- The study's findings may not apply to all healthcare settings.
- The impact of interventions on long-term patient outcomes is not fully assessed.
- Variability in provider engagement during interventions could influence results.
Entre Líneas
- The study's effectiveness remains unclear due to limited data on long-term outcomes.
- The sample size and demographic diversity may limit generalizability.
- The control group did not receive any intervention, which may affect comparative results.
Save this study
Keep this study in your Evidence Tracker so you can easily find it again whenever you need it.
Today's Activity
Your Evidence Workspace
Saved this study
Your free account becomes your personal diabetes evidence workspace.
Evidence Tracker
12 tracked topics
Saved Studies
48 studies
Research Notes
Coming Soon
Weekly Evidence Digest
Coming Soon
Connected Evidence
Explore related studies, evidence collections, and research questions.
Relationships organized using the Dediabetes Evidence Intelligence™ framework.
This study contributes to evidence on Group Meeting and GLP-1, Group Meeting and Insulin Prescribing.
Relaciones de evidencia relacionadas
Explore in Evidence ArchiveThis study contributes to the evidence on the following intervention-outcome relationships.
Group Meeting → GLP-1
Behavioral & Lifestyle
- ImpactScore™
- 100
- Very Positive
- EvidenceScore™
- Emerging
- Score 59 · Based on 1 study
- ConsistencyScore™
- unclear
- Not enough independent studies
Group Meeting → Insulin Prescribing
Behavioral & Lifestyle
- ImpactScore™
- 100
- Very Positive
- EvidenceScore™
- Emerging
- Score 59 · Based on 1 study
- ConsistencyScore™
- unclear
- Not enough independent studies
Incluido en estas colecciones de evidencia
Curated evidence collections and hubs this study is part of.
GLP-1 Evidence Hub
All studies measuring GLP-1
Measures GLP-1 as a key outcome.
Group Meeting Evidence Hub
All studies on Group Meeting
Contributes to Group Meeting evidence base.
Insulin Prescribing Evidence Hub
All studies measuring Insulin Prescribing
Measures Insulin Prescribing as a key outcome.
Recent Diabetes Research
Latest published studies
Published within the last 2 years.
Explora más en el archivo de evidencia
Jump to pre-filtered views in the evidence archive.
All studies on Group Meeting and GLP-1
1 results
All studies on Group Meeting and Insulin Prescribing
1 results
All studies on Group Meeting
1 results
All studies measuring GLP-1
1 results
All studies measuring Insulin Prescribing
1 results
Questions answered by this study
Generated from the study's connected evidence using Evidence Intelligence™.
Does Group Meeting improve glp-1?
Group Meeting appears to improve GLP-1.
ConsistencyScore™: Consistency cannot yet be determined from the available evidence.
Ranked evidence signals
- 1
GLP-1
EvidenceScore™ Emerging | EvidenceScore™ 59.0 | strong positive | ConsistencyScore™ Unclear | 1 study
Why this answer: This answer is based on a single supporting study.
Limitations
- Only one supporting study is available.
- Consistency cannot yet be determined.
- Population details are unavailable.
Does Group Meeting improve insulin prescribing?
Group Meeting appears to improve Insulin Prescribing.
ConsistencyScore™: Consistency cannot yet be determined from the available evidence.
Ranked evidence signals
- 1
Insulin Prescribing
EvidenceScore™ Emerging | EvidenceScore™ 59.0 | strong positive | ConsistencyScore™ Unclear | 1 study
Why this answer: This answer is based on a single supporting study.
Limitations
- Only one supporting study is available.
- Consistency cannot yet be determined.
- Population details are unavailable.
Does Group Meeting improve metformin prescribing?
Group Meeting appears to improve Metformin Prescribing.
ConsistencyScore™: Consistency cannot yet be determined from the available evidence.
Ranked evidence signals
- 1
Metformin Prescribing
EvidenceScore™ Emerging | EvidenceScore™ 59.0 | strong positive | ConsistencyScore™ Unclear | 1 study
Why this answer: This answer is based on a single supporting study.
Limitations
- Only one supporting study is available.
- Consistency cannot yet be determined.
- Population details are unavailable.
Does Group Meeting improve total t2d drugs prescribing?
Group Meeting appears to improve Total T2D Drugs Prescribing.
ConsistencyScore™: Consistency cannot yet be determined from the available evidence.
Ranked evidence signals
- 1
Total T2D Drugs Prescribing
EvidenceScore™ Emerging | EvidenceScore™ 59.0 | strong positive | ConsistencyScore™ Unclear | 1 study
Why this answer: This answer is based on a single supporting study.
Limitations
- Only one supporting study is available.
- Consistency cannot yet be determined.
- Population details are unavailable.
Next steps
Continue your research
Choose a next path through related evidence topics, archive views, and research summaries.
Explore in archive
Open broader archive views for this relationship.
Related research
Read related research summaries.
No ads. No tracking.
Focused on evidence, not advertising.
Secure & private
Your data is always protected.
Always up to date
New studies added every day.